Targeting Glycogen Synthase Kinase‐3<i>β</i> for Therapeutic Benefit against Oxidative Stress in Alzheimer′s Disease: Involvement of the Nrf2‐ARE Pathway

Katja M. Kanninen(University of Eastern Finland), Tarja Malm(University of Eastern Finland)
International Journal of Alzheimer s Disease
January 1, 2011
Cited by 67


Related Papers